Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep 2:2:RRN1177.
doi: 10.1371/currents.RRN1177.

Oncotype DX tumor gene expression profiling in stage II colon cancer. Application: prognostic, risk prediction

Elizabeth M Webber  1 , Jennifer S Lin, Evelyn P Whitlock
Affiliations

Oncotype DX tumor gene expression profiling in stage II colon cancer. Application: prognostic, risk prediction

Elizabeth M Webber et al. PLoS Curr. .

Abstract

Overall five-year survival for patients with stage-II colon cancer averages 75% after surgery alone. However, some of these patients have poorer outcomes, similar to patients with stage-III disease. The proposed use of the Oncotype DX assay is to improve risk stratification for recurrence in stage-II colon cancer.

PubMed Disclaimer

References

    1. Clark-Langone KM, Wu JY, Sangli C, et al. Biomarker discovery for colon cancer using a 761 gene RT-PCR assay. BMC Genomics. 2007;8:279. - PMC - PubMed
    1. O'Connell MJ, Yothers G, Paik S, et al. Relationship between tumor gene expression and recurrence in patients with stage II/III colon cancer treated with surgery + 5-FU/LV in NSABP C-06: Consistency of results with two other independent studies. Presented at: American Society of Clinical Oncology 2008 Gastrointestinal Cancers Symposium; January 25-27, 2008; Orlando, FL. Abstract 301.
    1. Lavery I, Hammel J, Cowens J, et al. Relationship between tumor gene expression and recurrence in an observational cohort of patients with stage II/III colon cancer treated with surgery only: Quantitative RT-PCR assay of 375 genes in fixed paraffin-embedded (FPE) tissue. Presented at: American Society of Clinical Oncology 2008 Gastrointestinal Cancers Symposium; January 25-27, 2008; Orlando, FL. Abstract 302.
    1. O’Connell MJ, Lavery IC, Gray RG et al Comparison of molecular and pathologic features of stage II and stage III colon cancer in four large studies conducted for development of the 12-gene colon cancer recurrence score. American Society of Clinical Oncology gastrointestinal Cancers Symposium, 2010, Abstract 280.
    1. Kerr D, Gray R, Quirke P, et al. A quantitative multigene RT-PCR assay for prediction of recurrence in stage II colon cancer: Selection of the genes in four large studies and results of the independent, prospectively designed QUASAR validation study [abstract 4000]. J Clin Oncol. 2009;27(suppl):15s.